Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review
- PMID: 26381811
- DOI: 10.1016/j.euroneuro.2015.07.028
Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review
Abstract
Modafinil is an FDA-approved eugeroic that directly increases cortical catecholamine levels, indirectly upregulates cerebral serotonin, glutamate, orexin, and histamine levels, and indirectly decreases cerebral gamma-amino-butrytic acid levels. In addition to its approved use treating excessive somnolence, modafinil is thought to be used widely off-prescription for cognitive enhancement. However, despite this popularity, there has been little consensus on the extent and nature of the cognitive effects of modafinil in healthy, non-sleep-deprived humans. This problem is compounded by methodological discrepancies within the literature, and reliance on psychometric tests designed to detect cognitive effects in ill rather than healthy populations. In order to provide an up-to-date systematic evaluation that addresses these concerns, we searched MEDLINE with the terms "modafinil" and "cognitive", and reviewed all resultant primary studies in English from January 1990 until December 2014 investigating the cognitive actions of modafinil in healthy non-sleep-deprived humans. We found that whilst most studies employing basic testing paradigms show that modafinil intake enhances executive function, only half show improvements in attention and learning and memory, and a few even report impairments in divergent creative thinking. In contrast, when more complex assessments are used, modafinil appears to consistently engender enhancement of attention, executive functions, and learning. Importantly, we did not observe any preponderances for side effects or mood changes. Finally, in light of the methodological discrepancies encountered within this literature, we conclude with a series of recommendations on how to optimally detect valid, robust, and consistent effects in healthy populations that should aid future assessment of neuroenhancement.
Keywords: Cognitive; Enhancement; Modafinil; Neuroenhancement; Nootropic; Psychometric.
Copyright © 2015 Elsevier B.V. and ECNP. All rights reserved.
Comment in
-
Correspondence arising: Modafinil for cognitive neuroenhancement in health non-sleep-deprived-subjects.Eur Neuropsychopharmacol. 2016 Feb;26(2):390. doi: 10.1016/j.euroneuro.2015.12.024. Epub 2015 Dec 10. Eur Neuropsychopharmacol. 2016. PMID: 26706693 No abstract available.
-
Correspondence arising: Modafinil for cognitive neuroenhancement in health non-sleep-deprived-subjects.Eur Neuropsychopharmacol. 2016 Feb;26(2):392-393. doi: 10.1016/j.euroneuro.2015.12.016. Epub 2015 Dec 11. Eur Neuropsychopharmacol. 2016. PMID: 26706695 No abstract available.
-
Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review.Eur Neuropsychopharmacol. 2016 Feb;26(2):391. doi: 10.1016/j.euroneuro.2015.12.023. Epub 2015 Dec 10. Eur Neuropsychopharmacol. 2016. PMID: 26708317 No abstract available.
-
Author׳s response on "Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review".Eur Neuropsychopharmacol. 2016 Feb;26(2):394-395. doi: 10.1016/j.euroneuro.2015.12.015. Epub 2015 Dec 12. Eur Neuropsychopharmacol. 2016. PMID: 26718790 No abstract available.
Similar articles
-
Pharmacotherapy for chronic cognitive impairment in traumatic brain injury.Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD009221. doi: 10.1002/14651858.CD009221.pub2. Cochrane Database Syst Rev. 2015. PMID: 26624881 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
-
Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation.Cochrane Database Syst Rev. 2022 Nov 25;11(11):CD011335. doi: 10.1002/14651858.CD011335.pub3. Cochrane Database Syst Rev. 2022. PMID: 36427235 Free PMC article.
-
Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain.Neuropharmacology. 2013 Jan;64:168-84. doi: 10.1016/j.neuropharm.2012.07.011. Epub 2012 Jul 20. Neuropharmacology. 2013. PMID: 22820555
Cited by
-
Vigilance Decrement and Enhancement Techniques: A Review.Brain Sci. 2019 Jul 26;9(8):178. doi: 10.3390/brainsci9080178. Brain Sci. 2019. PMID: 31357524 Free PMC article. Review.
-
Spontaneously Generated Online Patient Experience of Modafinil: A Qualitative and NLP Analysis.Front Digit Health. 2021 Feb 17;3:598431. doi: 10.3389/fdgth.2021.598431. eCollection 2021. Front Digit Health. 2021. PMID: 34713085 Free PMC article.
-
Pills or Push-Ups? Effectiveness and Public Perception of Pharmacological and Non-Pharmacological Cognitive Enhancement.Front Psychol. 2015 Dec 2;6:1852. doi: 10.3389/fpsyg.2015.01852. eCollection 2015. Front Psychol. 2015. PMID: 26696922 Free PMC article.
-
Not so smart? "Smart" drugs increase the level but decrease the quality of cognitive effort.Sci Adv. 2023 Jun 16;9(24):eadd4165. doi: 10.1126/sciadv.add4165. Epub 2023 Jun 14. Sci Adv. 2023. PMID: 37315143 Free PMC article.
-
Social Policy and Cognitive Enhancement: Lessons from Chess.Neuroethics. 2018;11(2):115-127. doi: 10.1007/s12152-018-9354-y. Epub 2018 Feb 22. Neuroethics. 2018. PMID: 29937945 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources